CURX: שווי חברה לרווח נקי curanexpharma.com

סמל ולוגו של המותג Curanex Pharmaceuticals (CURX)

Curanex Pharmaceuticals Inc (CURX) minimizes risks by developing various projects to combat infections and gastrointestinal pathologies. This price chart reflects a market trend for the asset with a value of -0.60. The company relies on external CDMO contractors for drug manufacturing while maintaining R&D operations in the US. However, the narrow specialization of its development portfolio could lead to a prolonged period of unprofitability.

CURX מכפיל P/E Curanex Pharmaceuticals (27.08.2025 - 16.11.2026)

פילוחי מדדים מקיפים ואנליטיקה עבור curanexpharma.com (CURX)

- מחיר ותחזית קונצנזוס למחירים:
ניתוח כללי של החברה:CURX, Curanex Pharma
מוצרים מוגמרים של Curanex Pharmaceuticals Inc

The P/E ratio determines the multiple of market capitalization to annual net income, reflecting the degree of an asset's overvaluation or the presence of a discount relative to its fundamental value. For Curanex Pharmaceuticals Inc (CURX), whose revenues depend on the outcome of clinical trials for gastrointestinal drugs, the company's calculated P/E serves as an indicator of market expectations until stable cash flows are established.